1-10 of 10
Michael J. Anderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B98: Final results of a randomized phase Ib study of fractionated 90Y-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having at least two prior therapies

Free
Vincent J. Picozzi, Ramesh K. Ramanathan, Maeve A. Lowery, Allyson J. Ocean, Edith P. Mitchell, Bert H. O'Neil, Michael J. Guarino, Paul R. Conkling, Steven J. Cohen, Nathan Bahary, Richard C. Frank, Tomislav Dragovich, Benjamin B. Bridges, Marie Lee, Ronald L. Korn, Neeta Pandit-Taskar, Stanley J. Goldsmith, Charles M. Intenzo, Arif Sheikh, Timothy C. Manzone, Michael L. Miller, Michael Yu, Judith M. Joyce, Edward B. Strauss, Susan Passalaqua, Ronald V. Dorn, III, Michael J. Anderson, Michael Holt, Fadi S. Braiteh, Fa-Chyi Lee, Thomas E. Gribbin, Donald A. Richards, Alexander N. Starodub, Wegener A. William, Eileen M. O'Reilly, Daniel D. Von Hoff, David M. Goldenberg
Journal: Cancer Research
Cancer Res (2015) 75 (13_Supplement): B98.
https://doi.org/10.1158/1538-7445.PANCA2014-B98
Published: 30 June 2015
View articletitled, Abstract B98: Final results of a randomized phase Ib study of fractionated 90Y-clivatuzumab tetraxetan in patients with metastatic pancreatic cancer having at least two prior therapies
Journal Articles

Abstract 3419: NOS1 imparts a survival benefit to PAX-FKHR expressing alveolar rhabdomyosarcomas

Free
Sheetal V. Bajaj, Violette Shahbazian, Michael J. Anderson, Timothy J. Triche
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 3419.
https://doi.org/10.1158/1538-7445.AM10-3419
Published: 15 April 2010
View articletitled, Abstract 3419: NOS1 imparts a survival benefit to PAX-FKHR expressing alveolar rhabdomyosarcomas
Journal Articles

Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells

Free
Kimberly A. Shafer-Weaver, Stephanie K. Watkins, Michael J. Anderson, Lauren J. Draper, Anatoli Malyguine, W. Gregory Alvord, Norman M. Greenberg, Arthur A. Hurwitz
Journal: Cancer Research
Cancer Res (2009) 69 (15): 6256–6264.
https://doi.org/10.1158/0008-5472.CAN-08-4516
Published: 29 July 2009
View articletitled, Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells
Open the PDF for Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells in another window
Includes: Supplementary data
Journal Articles

Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations

Free
Yue-Xin Ren, Friedrich Graf Finckenstein, Diana A. Abdueva, Violette Shahbazian, Brile Chung, Kenneth I. Weinberg, Timothy J. Triche, Hiroyuki Shimada, Michael J. Anderson
Journal: Cancer Research
Cancer Res (2008) 68 (16): 6587–6597.
https://doi.org/10.1158/0008-5472.CAN-08-0859
Published: 12 August 2008
View articletitled, Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations
Open the PDF for Mouse Mesenchymal Stem Cells Expressing PAX-FKHR Form Alveolar Rhabdomyosarcomas by Cooperating with Secondary Mutations in another window
Includes: Supplementary data
Journal Articles

Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas

Free
Elai Davicioni, Friedrich Graf Finckenstein, Violette Shahbazian, Jonathan D. Buckley, Timothy J. Triche, Michael J. Anderson
Journal: Cancer Research
Cancer Res (2006) 66 (14): 6936–6946.
https://doi.org/10.1158/0008-5472.CAN-05-4578
Published: 18 July 2006
View articletitled, Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas
Open the PDF for Identification of a PAX-FKHR Gene Expression Signature that Defines Molecular Classes and Determines the Prognosis of Alveolar Rhabdomyosarcomas in another window
Includes: Supplementary data
Journal Articles

The PAX-FKHR fusion proteins transcriptionally activate MyoD while inhibiting its function, thereby inducing a limited myogenic phenotype resembling that of alveolar rhabdomyosarcoma

Free
Friedrich Graf Finckenstein, Elai Davicioni, Violette Shahbazian, Michael J. Anderson
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1016–1017.
Published: 15 April 2006
View articletitled, The PAX-FKHR fusion proteins transcriptionally activate MyoD while inhibiting its function, thereby inducing a limited myogenic phenotype resembling that of alveolar rhabdomyosarcoma
Journal Articles

Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.

Free
Friedrich Graf Finckenstein, Elai Davicioni, Violette Shahbazian, Jonathan D. Buckley, Timothy J. Triche, Michael J. Anderson
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1324.
Published: 15 April 2006
View articletitled, Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.
Journal Articles

Whole genome analysis of expressed genes and loss of heterozygosity in rhabdomyosarcoma identifies molecular classes with prognostic significance

Free
Elai Davicioni, Michael J. Anderson, Friedrich Graf Finckenstein, Johnathan Buckley, Deborah Schofield, Timothy J. Triche
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1111.
Published: 01 May 2005
View articletitled, Whole genome analysis of expressed genes and loss of heterozygosity in rhabdomyosarcoma identifies molecular classes with prognostic significance
Journal Articles

Growth Suppression Mediated by Transfection of p53 in Hut292DM Human Lung Cancer Cells Expressing Endogenous Wild-Type p53 Protein

Free
Jean-François Cajot, Michael J. Anderson, Teresa A. Lehman, Harris Shapiro, Alicia A. Briggs, Eric J. Stanbridge
Journal: Cancer Research
Cancer Res (1992) 52 (24): 6956–6960.
Published: 01 December 1992
View articletitled, Growth Suppression Mediated by Transfection of p53 in Hut292DM Human Lung Cancer Cells Expressing Endogenous Wild-Type p53 Protein
Open the PDF for Growth Suppression Mediated by Transfection of p53 in Hut292DM Human Lung Cancer Cells Expressing Endogenous Wild-Type p53 Protein in another window
Journal Articles

Suppression of Tumorigenicity in Human Cell Hybrids Derived from Cell Lines Expressing Different Activated ras Oncogenes

Free
Andrew G. Geiser, Michael J. Anderson, Eric J. Stanbridge
Journal: Cancer Research
Cancer Res (1989) 49 (6): 1572–1577.
Published: 01 March 1989
View articletitled, Suppression of Tumorigenicity in Human Cell Hybrids Derived from Cell Lines Expressing Different Activated ras Oncogenes
Open the PDF for Suppression of Tumorigenicity in Human Cell Hybrids Derived from Cell Lines Expressing Different Activated ras Oncogenes in another window